PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PEN vs. MEDP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PEN and MEDP is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

PEN vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Penumbra, Inc. (PEN) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
55.61%
-13.08%
PEN
MEDP

Key characteristics

Sharpe Ratio

PEN:

0.28

MEDP:

-0.32

Sortino Ratio

PEN:

0.71

MEDP:

-0.17

Omega Ratio

PEN:

1.08

MEDP:

0.97

Calmar Ratio

PEN:

0.21

MEDP:

-0.39

Martin Ratio

PEN:

0.49

MEDP:

-0.70

Ulcer Index

PEN:

22.65%

MEDP:

18.34%

Daily Std Dev

PEN:

40.14%

MEDP:

40.30%

Max Drawdown

PEN:

-62.64%

MEDP:

-42.87%

Current Drawdown

PEN:

-11.71%

MEDP:

-24.78%

Fundamentals

Market Cap

PEN:

$11.70B

MEDP:

$10.48B

EPS

PEN:

$0.36

MEDP:

$12.62

PE Ratio

PEN:

843.78

MEDP:

27.26

PEG Ratio

PEN:

-62.27

MEDP:

1.86

Total Revenue (TTM)

PEN:

$1.19B

MEDP:

$2.11B

Gross Profit (TTM)

PEN:

$750.02M

MEDP:

$649.07M

EBITDA (TTM)

PEN:

$43.06M

MEDP:

$475.12M

Returns By Period

In the year-to-date period, PEN achieves a 27.91% return, which is significantly higher than MEDP's 3.53% return.


PEN

YTD

27.91%

1M

15.20%

6M

55.61%

1Y

13.09%

5Y*

9.64%

10Y*

N/A

MEDP

YTD

3.53%

1M

1.96%

6M

-13.08%

1Y

-10.46%

5Y*

28.26%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PEN vs. MEDP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PEN
The Risk-Adjusted Performance Rank of PEN is 5353
Overall Rank
The Sharpe Ratio Rank of PEN is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 5151
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 4949
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 5656
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 5252
Martin Ratio Rank

MEDP
The Risk-Adjusted Performance Rank of MEDP is 2828
Overall Rank
The Sharpe Ratio Rank of MEDP is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 2828
Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 2727
Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 2222
Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PEN vs. MEDP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PEN, currently valued at 0.28, compared to the broader market-2.000.002.000.28-0.32
The chart of Sortino ratio for PEN, currently valued at 0.71, compared to the broader market-4.00-2.000.002.004.006.000.71-0.17
The chart of Omega ratio for PEN, currently valued at 1.08, compared to the broader market0.501.001.502.001.080.97
The chart of Calmar ratio for PEN, currently valued at 0.21, compared to the broader market0.002.004.006.000.21-0.39
The chart of Martin ratio for PEN, currently valued at 0.49, compared to the broader market0.0010.0020.0030.000.49-0.70
PEN
MEDP

The current PEN Sharpe Ratio is 0.28, which is higher than the MEDP Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of PEN and MEDP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50SeptemberOctoberNovemberDecember2025February
0.28
-0.32
PEN
MEDP

Dividends

PEN vs. MEDP - Dividend Comparison

Neither PEN nor MEDP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PEN vs. MEDP - Drawdown Comparison

The maximum PEN drawdown since its inception was -62.64%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for PEN and MEDP. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%SeptemberOctoberNovemberDecember2025February
-11.71%
-24.78%
PEN
MEDP

Volatility

PEN vs. MEDP - Volatility Comparison

Penumbra, Inc. (PEN) has a higher volatility of 12.75% compared to Medpace Holdings, Inc. (MEDP) at 10.68%. This indicates that PEN's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%18.00%SeptemberOctoberNovemberDecember2025February
12.75%
10.68%
PEN
MEDP

Financials

PEN vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Penumbra, Inc. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab